NEW YORK: Havas Advertising has snapped up the US' largest
independent healthcare PR firm, Noonan/Russo Communications, for an
The agency, with worldwide revenues of $14 million, specializes
in healthcare and biotech PR. It will operate independently within
Havas' diversified agencies group, which is comprised of 50 specialized
"Noonan/Russo will fit in very well with Magnet and Abernathy MacGregor,
which we also recently acquired," said Simon Gillham, Havas' VP of
"The interesting thing about Noonan/Russo is it goes right across the
range in healthcare PR, from products to IR."
Susan Noonan, the firm's president and COO, said she wants the agency to
"build a much larger international footprint." Biotech is currently one
of the strongest parts of the firm's global business.
"Havas has a very strong respect for the entrepreneur," she said. "We
are excited to grow within the network, but still have autonomy in our
Noonan/Russo employs 200 people in three offices: New York, London, and
San Francisco. Noonan indicated that more staff will be added as a
result of the deal. The agency's clients include Genencor, Aventis,
Serono, DeCODE Genetics, and Myriad Genetics.